dyskinesia

1. Parkinson's disease; levodopa-induced dyskinesia; abnormal involuntary movements;
   帕金森病；左旋多巴诱发异动症；异常不自主运动；
2. Patients treated with STN stimulation also fared better in terms of on-phase motor UPDRS, dyskinesias UPDRS, median duration of dyskinesia, and reduction in antiparkinsonian drugs.
   用STN刺激作用对待的病人也按照在连线阶段的动量UPDRS，运动困难的UPDRS，中位数的持续时间的UPDRS，和抗巴金森氏症药物的减少使用。
3. An overactivation of glutamate signals, caused by treatment with levodopa, probably contributes to the development of dyskinesia.
   左旋多巴治疗所引起的谷氨酸表达的过于活跃，可能是异动症出现的原因。
4. Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.
   长期应用胃复安被证明与迟发型运动障碍相关，表现为机体的不随意和重复性的运动，即便服用时间不长（亦可出现）。
5. The study also found that "on" time without dyskinesia after awakening was more than doubled in the two rotigotine groups compared with placebo.
   本研究也发现唤醒后没有运动障碍的缓解期两种目标剂量的罗替戈汀组比安慰剂组长两倍多。
6. Study of Treatment Effect of Da Cheng Qi Tang Associates with Magnesium Sulfate on the Sphincter of Oddi Dyskinesia in Rabbits
   大承气汤联合硫酸镁治疗兔Oddi括约肌功能紊乱的实验研究
7. Melatonin in treatment of schizophrenia with tardive dyskinesia: A comparison study of cognitive function
   褪黑素治疗伴有迟发性运动障碍认知功能对照研究
8. The most severe consequence is that osteoporosis will easily cause fracture in hip, chest, waist and ankle as well as dyskinesia as a result of fracture.
   最严重的，骨质疏松极易造成髋部、胸腰椎与踝部的骨折，和因骨折而形成相应的运动障碍。
9. A diagnosis of probable reaction to cyclizine causing a lingual-facial-buccal dyskinesia was made.
   诊断考虑可能为赛克利嗪引起的舌-面-颊部运动障碍。
10. The Gene Mapping and Cloning in Chinese Pure Paroxysmal Kinesigenic Dyskinesia Pedigrees
    中国汉族单纯型发作性运动诱发性运动障碍家系的基因定位与克隆
11. Glutamate and Gamma-aminobutyric acid in rat model corpus striatum of Levodopa-induced Dyskinesia with deep brain stimulation
    脑深部电刺激对帕金森病异动症大鼠纹状体谷氨酸和γ-氨基丁酸含量影响的研究
12. Effect of Chaihu-Taoren Tang on tardive dyskinesia and the possible mechanism
    柴胡桃仁汤对迟发性运动障碍的治疗及可能机制
13. Therapeutic effects of EEG biofeedback in the treatment of chronic schizophrenics with tardive dyskinesia: a preliminary study
    脑电生物反馈对慢性精神分裂症迟发性运动障碍治疗效果的初步研究
14. Efficacy Analysis of Acute Cerebral Infarction Dyskinesia Treated with Early Promoting Nerve Unobstruction Technique and the Sound Combined with Electricity
    早期神经促进技术配合声、电联合治疗急性脑梗死运动障碍疗效分析
15. Current product labeling warns of the risk of tardive dyskinesia with chronic metoclopramide treatment.
    近期的产品标签已对长期应用甲氧氯普胺可导致迟发型运动障碍的风险提出警示。
16. We developed an experimental animal model of tardive dyskinesia simply by treating rats with neuroleptics.
    我们仅仅通过对大鼠施用神经松驰剂，就搞出了一个迟发性运动障碍的实验动物模型。
17. The activation of SOD and ATP in schizophrenic patients with tardive dyskinesia
    迟发性运动障碍患者超氧化物歧化酶、ATP酶活性改变
18. The mouth movements are a side effect ( not the actual condition) of taking antipsychotic meds, which is called tardive dyskinesia.
    这张嘴的动作是没病却吃称为“迟发性运动障碍”的精神病药物的副作用。
19. The effect of the cortical electrical stimulation on the expression of the c-fos and ENK in striatal neurons of rats with levodopa-induced dyskinesia
    皮层电刺激对左旋多巴诱发异动症大鼠纹状体c-fos及ENK表达的影响
20. Objective: To study effect of clonazepam on persistent tardive dyskinesia ( TD).
    目的：探讨氯硝西泮对持续性TD的临床作用。
21. Objective: To observe the recovery effect of early intervention on dyskinesia after acute cerebral apoplexy.
    目的观察急性脑卒中后肢体运动障碍的早期康复效果。
22. A case of primary ciliary dyskinesia was reported.
    本文报道一例原发性纤毛运动障碍患者的超微结构表现。
23. Incidence of anxiety and depression was higher in patients with dyskinesia-like FD.
    运动障碍样FD患者焦虑及抑郁的发病率较高。
24. Conclusions: Different types of paroxysmal dyskinesia had different induce factors and effect treated by carbamazepine was also different.
    结论不同类型的阵发性运动障碍诱发因素不同，对卡马西平的治疗效果也不同；
25. Persistent Tardive Dyskinesia Treated with Clonazepam
    氯硝西泮治疗持续性迟发性运动障碍
26. The results demonstrated that SV can improve dyskinesia for PD mice;
    结果表明：SV能改善PD小鼠运动功能障碍；
27. Objective: To investigate the causative drugs and clinical manifestations of drug-induced dyskinesia.
    目的：探讨致儿童药源性运动障碍的相关药物、影响因素及临床表现。
28. The evaluation of dyskinesia and rehabilitation for cerebral-palsy patients had important clinical value.
    小儿脑瘫患者的运动障碍分级和康复评估具有重要的临床价值。
29. Sphincter of Oddi dyskinesia is caused mainly by the lasting convulsion of SO.
    Oddi括约肌功能紊乱主要是因为SO的持续痉挛造成的。
30. Dyskinesia arose in another three patients, and it disappeared after adjusting the dose of levodopa compound preparations.
    另有3名患者在加用恩他卡朋后出现药源性的异动症，给予调整复方左旋多巴制剂的剂量后，异动症消失。

noun

1. abnormality in performing voluntary muscle movements